Stock 600750 JIANG ZHONG PHARMACEUTICAL CO.,LTD
Add to a list
To use this feature you must be a member
Log inSign up

Financials Jiang Zhong Pharmaceutical Co.,Ltd

Equities

600750

CNE000000M80

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
26.77 CNY -0.34% Intraday chart for Jiang Zhong Pharmaceutical Co.,Ltd -4.22% +28.21%
Mar. 25 Jiang Zhong Pharmaceutical Co.,Ltd Proposes Cash Dividend CI
Mar. 22 Jiang Zhong Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Capitalization 1 9,012 9,006 13,011 16,682 - -
Enterprise Value (EV) 1 9,012 9,006 11,680 15,408 15,607 15,787
P/E ratio 18.1 x 15.4 x 18.6 x 20.3 x 17.8 x 15.9 x
Yield - - 3.35% 5.14% 5.49% 5.85%
Capitalization / Revenue - - 2.96 x 3.37 x 2.96 x 2.65 x
EV / Revenue - - 2.66 x 3.11 x 2.77 x 2.51 x
EV / EBITDA - - 11.5 x 14.8 x 13.3 x 12 x
EV / FCF - - - - - -
FCF Yield - - - - - -
Price to Book - - 3.43 x 4.45 x 4.43 x 4.35 x
Nbr of stocks (in thousands) 623,700 623,282 623,145 623,145 - -
Reference price 2 14.45 14.45 20.88 26.77 26.77 26.77
Announcement Date 3/24/22 3/12/23 3/22/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net sales 1 - - 4,390 4,947 5,643 6,289
EBITDA 1 - - 1,015 1,042 1,172 1,318
EBIT 1 - - 894.1 981.6 1,134 1,259
Operating Margin - - 20.37% 19.84% 20.09% 20.02%
Earnings before Tax (EBT) 1 - - 897.1 1,047 1,192 1,344
Net income 1 505.7 596.1 708.3 831.7 946.9 1,062
Net margin - - 16.13% 16.81% 16.78% 16.89%
EPS 2 0.8000 0.9400 1.120 1.320 1.503 1.685
Free Cash Flow - - - - - -
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share 2 - - 0.7000 1.375 1.470 1.565
Announcement Date 3/24/22 3/12/23 3/22/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2023 Q4 2024 Q1 2025 Q1
Net sales - - - -
EBITDA - - - -
EBIT - - - -
Operating Margin - - - -
Earnings before Tax (EBT) - - - -
Net income 53.86 - - -
Net margin - - - -
EPS 1 0.0800 0.1900 0.4300 0.4400
Dividend per Share - - - -
Announcement Date 3/24/22 3/22/24 4/26/24 -
1CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - -
Net Cash position 1 - - 1,332 1,274 1,075 895
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - - - - - -
ROE (net income / shareholders' equity) - - 17.8% 22% 23% 27.5%
ROA (Net income/ Total Assets) - - - 12.3% 13.2% 13.5%
Assets 1 - - - 6,761 7,173 7,870
Book Value Per Share 2 - - 6.090 6.020 6.040 6.150
Cash Flow per Share 2 - - - 1.750 1.770 2.190
Capex 1 - - - 96 76 76
Capex / Sales - - - 1.94% 1.35% 1.21%
Announcement Date 3/24/22 3/12/23 3/22/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Jiang Zhong Pharmaceutical Co.,Ltd

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
26.77 CNY
Average target price
31.12 CNY
Spread / Average Target
+16.25%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
JIANG ZHONG PHARMACEUTICAL CO.,LTD Stock Jiang Zhong Pharmaceutical Co.,Ltd
+28.21% 2.3B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.00% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.09% 231B
NOVARTIS AG Stock Novartis AG
+5.46% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.61% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600750 Stock
  4. Financials Jiang Zhong Pharmaceutical Co.,Ltd